Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $539.51 | 42 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $311.19 | 29 | $0 (2024) |
| ABBVIE INC. | $70.60 | 5 | $0 (2024) |
| Amgen Inc. | $68.81 | 3 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $21.60 | 1 | $0 (2022) |
| Abbott Laboratories | $19.94 | 1 | $0 (2022) |
| Seqirus USA Inc | $17.44 | 1 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $16.73 | 1 | $0 (2023) |
| PFIZER INC. | $13.20 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $42.24 | 3 | Novo Nordisk Inc ($15.03) |
| 2023 | $130.79 | 7 | Amgen Inc. ($68.81) |
| 2022 | $234.23 | 20 | Novo Nordisk Inc ($163.91) |
| 2021 | $132.25 | 12 | Novo Nordisk Inc ($132.25) |
All Payment Transactions
42 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Obesity | ||||||
| 03/12/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: VACCINES | ||||||
| 03/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2023 | Seqirus USA Inc | FLUCELVAX QUADRIVALENT (Biological), Fluad Quadrivalent | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Vaccines | ||||||
| 09/08/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Inflammation | ||||||
| 08/09/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $33.13 | General |
| Category: Inflammation | ||||||
| 07/14/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Inflammation | ||||||
| 06/14/2023 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Respiratory | ||||||
| 04/20/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: NEUROSCIENCE | ||||||
| 11/29/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $8.67 | General |
| Category: Obesity | ||||||
| 11/08/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: NEUROSCIENCE | ||||||
| 10/26/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $8.20 | General |
| Category: Obesity | ||||||
| 10/04/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $8.50 | General |
| Category: Obesity | ||||||
| 09/14/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: Obesity | ||||||
| 08/25/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: Obesity | ||||||
| 08/09/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Obesity | ||||||
| 07/20/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $5.66 | General |
| Category: Obesity | ||||||
| 07/18/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: Central Nervous System | ||||||
| 06/07/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $9.05 | General |
| Category: Obesity | ||||||
| 05/19/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: Obesity | ||||||
| 04/21/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Obesity | ||||||
| 04/13/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $9.02 | General |
| Category: Obesity | ||||||
| 03/16/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $9.20 | General |
| Category: Obesity | ||||||
| 03/11/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 1 | 16 | 19 | $4,590 | $1,405 |
| 2020 | 3 | 92 | 133 | $23,119 | $6,062 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 16 | 19 | $4,590 | $1,405 | 30.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 55 | 92 | $18,681 | $5,003 | 26.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 26 | 28 | $3,843 | $955.91 | 24.9% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 11 | 13 | $596.20 | $102.69 | 17.2% |
About Amanda Uzzell, PA-C
Amanda Uzzell, PA-C is a Medical healthcare provider based in Piscataway, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/20/2011. The National Provider Identifier (NPI) number assigned to this provider is 1619252665.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amanda Uzzell, PA-C has received a total of $539.51 in payments from pharmaceutical and medical device companies, with $42.24 received in 2024. These payments were reported across 42 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($539.51).
As a Medicare-enrolled provider, Uzzell has provided services to 108 Medicare beneficiaries, totaling 152 services with total Medicare billing of $7,467. Data is available for 2 years (2020–2021), covering 4 distinct procedure/service records.
Practice Information
- Specialty Medical
- Location Piscataway, NJ
- Active Since 10/20/2011
- Last Updated 10/20/2011
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1619252665
Products in Payments
- Saxenda (Drug) $204.30
- Wegovy (Drug) $106.89
- Otezla (Drug) $68.81
- VRAYLAR (Drug) $43.14
- AUSTEDO (Drug) $21.60
- FREESTYLE LIBRE 2 (Device) $19.94
- FLUCELVAX QUADRIVALENT (Biological) $17.44
- BEVESPI AEROSPHERE (Drug) $16.73
- UBRELVY (Drug) $15.10
- PREVNAR 20 (Biological) $13.20
- QULIPTA (Drug) $12.36
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.